BloodTrackR Usability and Concordance Study (BUCS): Evaluating a Smart Home-Based Blood Collection Platform for Remote Monitoring in Rheumatoid Arthritis
Recruiting · NCT07660029 · Observational (researchers observe without assigning treatment) · Lead sponsor: University of Ulster
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The BloodTrackR Usability and Concordance Study (BUCS) is evaluating a novel home-based blood collection device and companion mobile application for people with rheumatoid arthritis. Participants will use the BloodTrackR device to collect a finger-prick blood sample at home and complete symptom assessments through the app. The study will assess how easy the device and app are to use, whether participants can successfully collect high-quality blood samples outside of a healthcare setting, and how closely the results compare with standard venous blood samples collected by a phlebotomist. Findings will help determine the potential of BloodTrackR to support remote monitoring and reduce reliance on NHS phlebotomy services.
Who can take part
Inclusion criteria
- Individuals living with rheumatoid arthritis, who attend community groups or rheumatoid arthritis charity groups
- Aged 18 years or older
- Able to understand written and spoken English
- Individuals who have the capacity to consent
- Access to WiFi and a smartphone/tablet
Exclusion criteria
- Participants \<18years
- Participants taking antibiotics/antivirals
- No access to WiFi or a smartphone/tablet
Where it is running
1 location listed.
- Personalised Medicine Centre - Londonderry, United Kingdom